{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:37:55Z","timestamp":1786991875890,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jconrel.2022.12.061","type":"journal-article","created":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T13:36:52Z","timestamp":1673530612000},"page":"268-278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment"],"prefix":"10.1016","volume":"354","author":[{"given":"Taebum","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Sub","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.12.061_bb0005","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/5289","article-title":"Cancer multidrug resistance","volume":"17","author":"Persidis","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(88)90568-5","article-title":"An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene","volume":"53","author":"Choi","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drup.2016.05.001","article-title":"Overcoming ABC transporter-mediated multidrug resistance: molecular mechanisms and novel therapeutic drug strategies","volume":"27","author":"Li","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ijlh.12928","article-title":"Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and\/or tyrosine kinase domain mutations","volume":"41","author":"Xue","year":"2019","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0025","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00277-012-1591-2","article-title":"Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia","volume":"92","author":"Tiribelli","year":"2013","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drup.2015.08.004","article-title":"Microenvironment acidity as a major determinant of tumor chemoresistance: proton pump inhibitors (PPIs) as a novel therapeutic approach","volume":"23","author":"Taylor","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0035","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/cancers10120471","article-title":"Chemoresistance and the self-maintaining tumor microenvironment","volume":"10","author":"Yeldag","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0040","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.3390\/ijms18122574","article-title":"Drug resistance driven by cancer stem cells and their niche","volume":"18","author":"Prieto-Vila","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drup.2016.06.006","article-title":"The bad seed: Cancer stem cells in tumor development and resistance","volume":"28","author":"Koren","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/s41568-018-0005-8","article-title":"Revisiting the role of ABC transporters in multidrug-resistant cancer","volume":"18","author":"Robey","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrd1984","article-title":"Targeting multidrug resistance in cancer","volume":"5","author":"Szak\u00e1cs","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0060","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/107327480301000207","article-title":"Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein","volume":"10","author":"Thomas","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0169-409X(02)00175-8","article-title":"Considerations in the design and development of transport inhibitors as adjuncts to drug therapy","volume":"55","author":"Dantzig","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0070","doi-asserted-by":"crossref","first-page":"7216","DOI":"10.1021\/jm500290c","article-title":"Water-soluble and cleavable quercetin\u2013amino acid conjugates as safe modulators for P-glycoprotein-based multidrug resistance","volume":"57","author":"Kim","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0075","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/mp400596v","article-title":"Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells","volume":"11","author":"Chen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bioactmat.2020.06.012","article-title":"Recent advances of two-dimensional materials in smart drug delivery nano-systems","volume":"5","author":"Zhang","year":"2020","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0085","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archsurg.1997.01430320105017","article-title":"Frequency and duration of remission after isolated limb perfusion for melanoma","volume":"132","author":"Thompson","year":"1997","journal-title":"Arch. Surg."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/metabo8010002","article-title":"Rethinking the combination of proton exchanger inhibitors in cancer therapy","volume":"8","author":"Iessi","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0095","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1177\/089719009901200608","article-title":"Pantoprazole: a new proton-pump inhibitor","volume":"12","author":"Dombrower","year":"1999","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0100","doi-asserted-by":"crossref","first-page":"58801","DOI":"10.18632\/oncotarget.18522","article-title":"Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0105","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10637-014-0159-5","article-title":"A phase I trial of pantoprazole in combination with doxorubicin in patients with advanced solid tumors: evaluation of pharmacokinetics of both drugs and tissue penetration of doxorubicin","volume":"32","author":"Brana","year":"2014","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2867-13-89","article-title":"Acidic extracellular microenvironment and cancer","volume":"13","author":"Kato","year":"2013","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0115","series-title":"Seminars in cancer Biology","first-page":"74","article-title":"Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation","author":"Huber","year":"2017"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.abb.2009.03.003","article-title":"Characterization of the ATPase activity of a novel chimeric fusion protein consisting of the two nucleotide binding domains of MRP1","volume":"485","author":"Wan","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0125","first-page":"353","article-title":"Overview of P-glycoprotein inhibitors: a rational outlook, Brazilian","volume":"48","author":"Srivalli","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00210-001-0489-7","article-title":"Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein","volume":"364","author":"Pauli-Magnus","year":"2001","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0135","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1124\/jpet.106.101154","article-title":"A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system","volume":"317","author":"Wong","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0140","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1126\/science.1970196","article-title":"Shared actions of endotoxin and taxol on TNF receptors and TNF release","volume":"248","author":"Ding","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0145","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1074\/jbc.275.4.2251","article-title":"Mouse toll-like receptor 4\u00b7 MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol","volume":"275","author":"Kawasaki","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2020.06.022","article-title":"Recent advancements in liposome technology","volume":"156","author":"Filipczak","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0155","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1158\/1078-0432.CCR-13-0128","article-title":"Use of the proton pump inhibitor pantoprazole to modify the distribution and activity of doxorubicin: a potential strategy to improve the therapy of solid tumors","volume":"19","author":"Patel","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.canlet.2014.10.017","article-title":"Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma","volume":"356","author":"Azzarito","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics8020012","article-title":"Evaluation of P-glycoprotein inhibitory potential using a rhodamine 123 accumulation assay","volume":"8","author":"Jouan","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0175","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/0024-3205(82)90455-6","article-title":"Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components","volume":"30","author":"Senior","year":"1982","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109478","article-title":"Pantoprazole pretreatment elevates sensitivity to vincristine in drug-resistant oral epidermoid carcinoma in vitro and in vivo","volume":"120","author":"Lu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0185","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/j.bioactmat.2021.01.026","article-title":"Metal peroxides for cancer treatment","volume":"6","author":"He","year":"2021","journal-title":"Bioactive Mater."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0190","doi-asserted-by":"crossref","first-page":"36882","DOI":"10.1021\/acsami.0c09110","article-title":"Photosensitizer-doped and plasma membrane-responsive liposomes for nuclear drug delivery and multidrug resistance reversal","volume":"12","author":"Zhu","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0195","doi-asserted-by":"crossref","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","article-title":"Lipids and lipid derivatives for RNA delivery","volume":"121","author":"Zhang","year":"2021","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","article-title":"Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids","volume":"107","author":"Heyes","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0205","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0959-8049(94)90187-2","article-title":"A comparison of rhodamine 123 accumulation and efflux in cells with P-glycoprotein-mediated and MRP-associated multidrug resistance phenotypes","volume":"30","author":"Twentyman","year":"1994","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0210","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/bjc.2015.17","article-title":"Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy","volume":"112","author":"Tan","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0215","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/yea.1284","article-title":"Paclitaxel-induced microtubule stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of Saccharomyces cerevisiae","volume":"22","author":"Foland","year":"2005","journal-title":"Yeast"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0220","first-page":"4955","article-title":"Subcellular distribution of daunorubicin in P-glycoprotein-positive and-negative drug-resistant cell lines using laser-assisted confocal microscopy","volume":"51","author":"Gervasoni","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0225","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1023\/A:1026732405381","article-title":"Detection of P-glycoprotein in the nuclear envelope of multidrug resistant cells","volume":"32","author":"Calcabrini","year":"2000","journal-title":"Histochem. J."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0230","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.4161\/cc.6.22.4936","article-title":"What makes tumors multidrug resistant?","volume":"6","author":"Borst","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0235","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2174\/138920009790274540","article-title":"Therapeutic nanoparticles to combat cancer drug resistance","volume":"10","author":"Hu","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0240","series-title":"Multi-drug resistance in cancer","first-page":"467","article-title":"Circumventing tumor resistance to chemotherapy by nanotechnology","author":"Liang","year":"2010"},{"key":"10.1016\/j.jconrel.2022.12.061_bb0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejps.2009.08.009","article-title":"Paclitaxel and immune system","volume":"38","author":"Javeed","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s11658-019-0164-y","article-title":"Progress in research on paclitaxel and tumor immunotherapy","volume":"24","author":"Zhu","year":"2019","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0255","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1158\/1078-0432.CCR-07-0517","article-title":"Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth","volume":"13","author":"Zhong","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0260","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002620000122","article-title":"The immunological effects of taxanes","volume":"49","author":"Chan","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2022.12.061_bb0265","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","article-title":"In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy","volume":"72","author":"Kim","year":"2001","journal-title":"J. Control. Release"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922008756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:36:01Z","timestamp":1759163761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922008756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"alternative-id":["S0168365922008756"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.061","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanocracker capable of simultaneously reversing both P-glycoprotein and tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.12.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}